IT3 Medical LLC drugs

37 results
  • IT3 Medical LLC
    Usage: Ketorolac tromethamine is indicated for short-term management (≤5 days) of moderately severe acute pain requiring analgesia equivalent to opioids, typically postoperatively. Initial therapy should be via IV or IM; oral ketorolac is for continuation only. Total use must not exceed 5 days to mitigate adverse reactions.
  • IT3 Medical LLC
    Usage: Ketorolac tromethamine is indicated for short-term management (≤5 days) of moderately severe acute pain requiring opioid-level analgesia, primarily in postoperative settings. Initial treatment should be intravenous or intramuscular, with oral use only for continuation. Total use should not exceed 5 days to minimize adverse reactions.
  • IT3 Medical LLC
    Usage: Ketorolac tromethamine is indicated for short-term (≤5 days) management of moderately severe acute pain, typically postoperatively. It should be administered via IV or IM, with oral use reserved for continuation. Total use should not exceed 5 days to limit adverse reaction risks.
  • IT3 Medical LLC
    Usage: This drug is indicated for use in preparing the skin before an injection to reduce the risk of infection and ensure a sterile environment.
  • IT3 Medical LLC
    Usage: This parenteral preparation is indicated for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, as per the manufacturer's instructions for the specific drug.
  • IT3 Medical LLC
    Usage: This drug is indicated for diluting or dissolving medications for intravenous, intramuscular, or subcutaneous injection, following the manufacturer's instructions. It is strictly not for inhalation use.
  • Dromelate (dihydroergotamine mesylate)

    (Dihydroergotamine Mesylate)
    IT3 Medical LLC
    Usage: Dihydroergotamine Mesylate Injection is indicated for the acute treatment of migraine headaches (with or without aura) and cluster headache episodes.